We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
87.4% of bluebird bio shares are held by institutional investors. 1.4% of bluebird bio shares are held by company insiders. Comparatively, 7.6% of SpringWorks Therapeutics shares are held by ...
Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of bluebird bio, Inc. (NasdaqGS: BLUE) to Carlyle Group and SK Capital Partners ...
Fintel reports that on February 24, 2025, JP Morgan upgraded their outlook for bluebird bio (NasdaqGS:BLUE) from Underweight to Neutral. Analyst Price Forecast Suggests 807.14% Upside As of ...
Shares of bluebird bio (NASDAQ:BLUE) continued their downward descent Monday in the wake of news that the company has agreed to be taken private by Carlyle Group (NASDAQ:CG) and SK Capital ...
Wells Fargo analyst Yanan Zhu lowered the firm’s price target on Bluebird Bio (BLUE) to $5 from $40 and keeps an Equal Weight rating on the shares after the company announced that it has entered ...
--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird”) today announced that it has entered into a definitive agreement to be acquired by funds managed by global investment firms Carlyle ...
Forbes contributors publish independent expert analyses and insights. I write about the world of biology.
bluebird bio stock opened at $4.08 on Friday. The firm has a market capitalization of $39.66 million, a P/E ratio of -0.11 and a beta of 0.68. The stock has a fifty day moving average price of $7. ...
As we know from something that did not happen on Tuesday, the Blue Jays had their first full squad workout for the spring and are preparing to play the New York Yankees in their 2025 Grapefruit ...
WHITEFIELD, BANGALORE, KARNATAKA, INDIA, February 21, 2025 /EINPresswire.com/ -- Bird Nest Interiors, a leading interior design firm based in Whitefield, Bangalore ...